{"transactions":[{"id":2366646,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":129830,"kind":"person","name":"Schott Robert J.","position":1,"cik":"0001845310","reported_name":"Schott Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T22:20:46.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":110700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":110700,"derivative":{"exercise_price":5.9,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":110700},"source":{"system":"sec-edgar","filing":"0001209191-22-014176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014176/doc4.xml","form_type":"4"}},{"id":2366645,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":129830,"kind":"person","name":"Schott Robert J.","position":1,"cik":"0001845310","reported_name":"Schott Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Development"}}],"security":"Common Stock","published_at":"2022-03-01T22:20:46.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,668 shares subject to the Reporting Person's February 12, 2021 RSU grant that will vest in two remaining annual installments of 13,332 shares and 13,336 shares on February 12, 2023 and 2024, respectively, subject to Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":75537,"source":{"system":"sec-edgar","filing":"0001209191-22-014176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014176/doc4.xml","form_type":"4"}},{"id":2375979,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":129830,"kind":"person","name":"Schott Robert J.","position":1,"cik":"0001845310","reported_name":"Schott Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Development"}}],"security":"Common Stock","published_at":"2022-02-24T22:32:27.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":5463,"price":5.76,"value":31466.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on February 12, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 11, 2022 of $5.76/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,869 shares resulting from the February 12, 2022 vesting of the Reporting Person's February 12, 2021 RSU grant and 26,668 shares subject to such RSU grant that will vest in two remaining annual installments of 13,332 shares and 13,336 shares on February 12, 2023 and 2024, respectively. The vesting of all such RSUs is subject to the Reporting Person's continuous service as defined in the Issuer's 2018 EIP through such dates and subject to acceleration as defined in the 2018 EIP."}],"balance_after":34537,"source":{"system":"sec-edgar","filing":"0001209191-22-012765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122012765/doc4.xml","form_type":"4"}},{"id":2860322,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":129830,"kind":"person","name":"Schott Robert J.","position":1,"cik":"0001845310","reported_name":"Schott Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T23:21:13.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the February 12, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended.\nRemarks:"}],"balance_after":80000,"derivative":{"exercise_price":13.68,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-010954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121010954/doc4.xml","form_type":"4"}},{"id":2860321,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":129830,"kind":"person","name":"Schott Robert J.","position":1,"cik":"0001845310","reported_name":"Schott Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Development"}}],"security":"Common Stock","published_at":"2021-02-16T23:21:13.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 40,000 shares of common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person on February 12, 2021. The RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-21-010954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121010954/doc4.xml","form_type":"4"}}]}